Готові списки джерел за темами / Ocular plastics

Добірка наукової літератури з теми "Ocular plastics"

Автор: Grafiati

Опубліковано: 10 грудня 2022

Оновлено: 28 січня 2023

Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями

Оберіть тип джерела:

Зміст

Статті в журналах
Дисертації
Книги
Частини книг
Тези доповідей конференцій

Ознайомтеся зі списками актуальних статей, книг, дисертацій, тез та інших наукових джерел на тему "Ocular plastics".

Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.

Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.

Статті в журналах з теми "Ocular plastics"

Pandey, Manisha, Hira Choudhury, Azila binti Abd Aziz, Subrat Kumar Bhattamisra, Bapi Gorain, Jocelyn Sziou Ting Su, Choo Leey Tan, Woon Yee Chin, and Khar Yee Yip. "Potential of Stimuli-Responsive In Situ Gel System for Sustained Ocular Drug Delivery: Recent Progress and Contemporary Research." Polymers 13, no. 8 (April 20, 2021): 1340. http://dx.doi.org/10.3390/polym13081340.

Повний текст джерела

Анотація:

Eyesight is one of the most well-deserved blessings, amid all the five senses in the human body. It captures the raw signals from the outside world to create detailed visual images, granting the ability to witness and gain knowledge about the world. Eyes are exposed directly to the external environment; they are susceptible to the vicissitudes of diseases. The World Health Organization has predicted that the number of individuals affected by eye diseases will rise enormously in the next decades. However, the physical barriers of the eyes and the problems associated with conventional ocular formulations are significant challenges in ophthalmic drug development. This has generated the demand for a sustained ocular drug delivery system, which serves to deliver effective drug concentration at a reduced frequency for consistent therapeutic effect and better patient treatment adherence. Recent advancement in pharmaceutical dosage design has demonstrated that a stimuli-responsive in situ gel system exhibits the favorable characteristics for providing sustained ocular drug delivery and enhanced ocular bioavailability. Stimuli-responsive in situ gels undergo a phase transition (solution–gelation) in response to the ocular environmental temperature, pH, and ions. These stimuli transform the formulation into a gel at the cul de sac to overcome the shortcomings of conventional eye drops, such as rapid nasolacrimal drainage and short contact time with the ocular surface This review highlights the recent successful research outcomes of stimuli-responsive in situ gelling systems in treating in vivo models with glaucoma and various ocular infections. Additionally, it also presents the mechanism, recent development, and safety considerations of stimuli-sensitive in situ gel as the potential sustained ocular delivery system for treating common eye disorders.

Стилі APA, Harvard, Vancouver, ISO та ін.

Islam, Ahmed Tanjimul, Mohammad Golam Rabbani, and Subrata Dey. "Orbital and Ocular Manifestations of Acute Leukemia: Clinical Analysis in a Tertiary Care Hospital." Journal of Chittagong Medical College Teachers' Association 26, no. 1 (September 13, 2015): 21–24. http://dx.doi.org/10.3329/jcmcta.v26i1.61811.

Повний текст джерела

Анотація:

To determine the prevalence of orbital and ocular manifestations in acute leukemia at the time of presentation, sixty (60) patients diagnosed with acute leukemia were examined for ocular lesions by within two weeks of diagnosis before starting chemotherapy. The detailed ocular examination of both eyes was carried out by the ophthalmologist irrespective of the presence or absence of eye symptoms in all cases. Only 3 out of 60 patients presented with eye symptoms (5%). However, ocular changes were found in 16 patients (26%), 11 with lymphoblastic and 5 with myeloid leukemia. The ocular lesions observed were Intraretinal hemorrhages, decreased Visual acuity, Proptosis, Macular hemorrhage, Cotton wool spots, Papilloedema, Vitrious hemorrhage and Sixth nerve palsy. In view of the high prevalence of asymptomatic ocular lesions in acute leukemia, routine Ophthalmic Examination should be included as a part of evaluation at the time of diagnosis. JCMCTA 2015 ; 26 (1) : 21-24

Стилі APA, Harvard, Vancouver, ISO та ін.

Dludla, Siphokazi B. K., Leshasha T. Mashabela, Brian Ng’andwe, Pedzisai A. Makoni, and Bwalya A. Witika. "Current Advances in Nano-Based and Polymeric Stimuli-Responsive Drug Delivery Targeting the Ocular Microenvironment: A Review and Envisaged Future Perspectives." Polymers 14, no. 17 (August 30, 2022): 3580. http://dx.doi.org/10.3390/polym14173580.

Повний текст джерела

Анотація:

Optimal vision remains one of the most essential elements of the sensory system continuously threatened by many ocular pathologies. Various pharmacological agents possess the potential to effectively treat these ophthalmic conditions; however, the use and efficacy of conventional ophthalmic formulations is hindered by ocular anatomical barriers. Recent novel designs of ophthalmic drug delivery systems (DDS) using nanotechnology show promising prospects, and ophthalmic formulations based on nanotechnology are currently being investigated due to their potential to bypass these barriers to ensure successful ocular drug delivery. More recently, stimuli-responsive nano drug carriers have gained more attention based on their great potential to effectively treat and alleviate many ocular diseases. The attraction is based on their biocompatibility and biodegradability, unique secondary conformations, varying functionalities, and, especially, the stimuli-enhanced therapeutic efficacy and reduced side effects. This review introduces the design and fabrication of stimuli-responsive nano drug carriers, including those that are responsive to endogenous stimuli, viz., pH, reduction, reactive oxygen species, adenosine triphosphate, and enzymes or exogenous stimuli such as light, magnetic field or temperature, which are biologically related or applicable in clinical settings. Furthermore, the paper discusses the applications and prospects of these stimuli-responsive nano drug carriers that are capable of overcoming the biological barriers of ocular disease alleviation and/or treatment for in vivo administration. There remains a great need to accelerate the development of stimuli-responsive nano drug carriers for clinical transition and applications in the treatment of ocular diseases and possible extrapolation to other topical applications such as ungual or otic drug delivery.

Стилі APA, Harvard, Vancouver, ISO та ін.

Banshchikov, P. A., O. V. Kolenko, V. V. Egorov, and G. P. Smoliakova. "Complex surgical reconstruction of the ocular surface, eyelids, lacrimal ducts and orbit after severe combined injury (clinical case)." Modern technologies in ophtalmology, no. 2 (April 13, 2022): 204–10. http://dx.doi.org/10.25276/2312-4911-2022-2-204-210.

Повний текст джерела

Анотація:

The article presents clinical case of severe combined injury ocular surface, ocular adnexa, lacrimal duct, orbital walls. The article describes a staged complex surgical rehabilitation, performed in the Khabarovsk branch of the S. Fyodorov Eye Microsurgery Federal State Institution: of orbital walls with “Ekoflon” material (Russia), of lacrimal duct by Taumi method, of medial palpebral ligament, of upper eyelid coloboma with free skin graft; locomotory stump and ocular cosmetic prosthesis after evisceration. In the long-term period (14 months), restoration of the eyelids anatomy, the measures of the palpebral fissure, the mobility of the upper eyelid, positive function of lacrimation, normal positioning and good eye prosthesis movement was noted. Keywords: combined ocular injury, reconstructive and cosmetic eyelid surgery, lacrimal duct reconstruction; periorbital reconstruction; eye prosthesis.

Стилі APA, Harvard, Vancouver, ISO та ін.

Akhter, Md Habban, Irfan Ahmad, Mohammad Y. Alshahrani, Alhanouf I. Al-Harbi, Habibullah Khalilullah, Obaid Afzal, Abdulmalik S. A. Altamimi, Shehla Nasar Mir Najib Ullah, Abhijeet Ojha, and Shahid Karim. "Drug Delivery Challenges and Current Progress in Nanocarrier-Based Ocular Therapeutic System." Gels 8, no. 2 (January 28, 2022): 82. http://dx.doi.org/10.3390/gels8020082.

Повний текст джерела

Анотація:

Drug instillation via a topical route is preferred since it is desirable and convenient due to the noninvasive and easy drug access to different segments of the eye for the treatment of ocular ailments. The low dose, rapid onset of action, low or no toxicity to the local tissues, and constrained systemic outreach are more prevalent in this route. The majority of ophthalmic preparations in the market are available as conventional eye drops, which rendered <5% of a drug instilled in the eye. The poor drug availability in ocular tissue may be attributed to the physiological barriers associated with the cornea, conjunctiva, lachrymal drainage, tear turnover, blood–retinal barrier, enzymatic drug degradation, and reflex action, thus impeding deeper drug penetration in the ocular cavity, including the posterior segment. The static barriers in the eye are composed of the sclera, cornea, retina, and blood–retinal barrier, whereas the dynamic barriers, referred to as the conjunctival and choroidal blood flow, tear dilution, and lymphatic clearance, critically impact the bioavailability of drugs. To circumvent such barriers, the rational design of the ocular therapeutic system indeed required enriching the drug holding time and the deeper permeation of the drug, which overall improve the bioavailability of the drug in the ocular tissue. This review provides a brief insight into the structural components of the eye as well as the therapeutic challenges and current developments in the arena of the ocular therapeutic system, based on novel drug delivery systems such as nanomicelles, nanoparticles (NPs), nanosuspensions, liposomes, in situ gel, dendrimers, contact lenses, implants, and microneedles. These nanotechnology platforms generously evolved to overwhelm the troubles associated with the physiological barriers in the ocular route. The controlled-drug-formulation-based strategic approach has considerable potential to enrich drug concentration in a specific area of the eye.

Стилі APA, Harvard, Vancouver, ISO та ін.

Zhang, Xiaodan, Danyi Wei, Yang Xu, and Qiang Zhu. "Hyaluronic acid in ocular drug delivery." Carbohydrate Polymers 264 (July 2021): 118006. http://dx.doi.org/10.1016/j.carbpol.2021.118006.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Lebed, E. A. "Сlinical case: post ocular (?) complications in the ocular fundus in the form of a congested optic disc in both eyes". Modern technologies in ophtalmology, № 6 (9 листопада 2022): 114–18. http://dx.doi.org/10.25276/2312-4911-2022-6-114-118.

Повний текст джерела

Анотація:

Since December 2019, an epidemic of a new coronavirus infection COVID-19 has been identified in the world. This disease is characterized by a severe course, high mortality, airborne transmission, high contagiousness. During the treatment of the disease and complications after the infection, distant complications in the organs and systems began to appear. Based on experience, the route of transmission of the virus has been proven, as well as the pathogenesis of the disease, long-term complications, in particular in ophthalmology, has been identified. When infected with SARS-CoV-2, there is a violation of blood rheology – an increase in blood coagulation (hypercoagulation), which leads to the formation of blood clots and occlusion in the vascular bed and disruption of the microvasculature. Keywords: COVID-19, optic disc congestion, partial optic disc atrophy

Стилі APA, Harvard, Vancouver, ISO та ін.

Mittal, Neeraj, and Gurpreet Kaur. "Investigations on Polymeric Nanoparticles for Ocular Delivery." Advances in Polymer Technology 2019 (June 2, 2019): 1–14. http://dx.doi.org/10.1155/2019/1316249.

Повний текст джерела

Анотація:

In the present investigation, an attempt was made to formulate timolol maleate (TML) loaded polymeric nanoparticles of flax seed gum (FX) and chitosan (CH) for ocular delivery using ionic gelation method. The process of nanoparticle preparation was optimized using 2-factor, 3-level central composite experimental design. The optimal concentration of FX and CH that yielded nanoparticles with minimum particle size (267.06 ± 8.65 nm) and maximum encapsulation efficiency (74.96 ± 4.78%) was found to be 0.10% w/v and 0.08% w/v, respectively. The formulated nanoparticles revealed considerable bioadhesive strength and exhibited sustained release of drug in in vitro diffusion studies. The ex vivo transcorneal penetration study revealed higher corneal penetration of TML compared to marketed eye drops. The confocal scanning laser microscopy (CSLM) studies also confirmed the ability of nanoparticles to penetrate into deeper layers of cornea. The histopathological studies revealed corneal biocompatibility of nanoparticles. The nanoparticles were found to reduce the intra ocular pressure (IOP) in rabbits for prolonged period when compared to conventional eye drops. The results of the present study suggested a promising role of polymeric nanoparticles for ocular drug delivery in treatment of glaucoma.

Стилі APA, Harvard, Vancouver, ISO та ін.

Aslam, Mohammed, Syed Sarim Imam, Mohammed Aqil, Yasmin Sultana, and Asgar Ali. "Levofloxacin loaded gelrite-cellulose polymer based sustained ocular drug delivery: formulation, optimization and biological study." Journal of Polymer Engineering 36, no. 8 (October 1, 2016): 761–69. http://dx.doi.org/10.1515/polyeng-2015-0218.

Повний текст джерела

Анотація:

Abstract In the present work, levofloxacin in situ gel formulation was developed using gelrite as a gelling agent in combination with hydroxy propyl methyl cellulose. The developed formulations were evaluated for physicochemical parameters, in vitro release, ex vivo transcorneal study, sterility testing, antimicrobial efficacy, ocular irritation study, histopathological and stability evaluation. The in vitro drug release study showed the extended drug release up to 12 h, and the best fit kinetic model was found to be Peppas model (R2=0.9654), suggesting a Fickian diffusion process. The developed formulations showed optimized physicochemical results for all parameters. The optimized formulation showed therapeutically efficacious antimicrobial activity. Hens egg test-chorioallantoin membrane assay (HET-CAM) showed a mean score of 0.33 up to 24 h, which indicated the non-irritant property of the developed formulation. This non-irritant and stable in situ gel formulation of levofloxacin was found to be promising and safe for use as ocular delivery. The degradation rate constant and shelf life of developed optimized formulation (F14) were found to be low (1.213×10-4 at 25°C) and 2.14 years, respectively. This renders them favorable for ocular use as they would gel once in contact with the tear fluid, thus reducing nasolacrimal drainage, but would thin upon shearing, preventing ocular irritation and therefore induced lacrimation.

Стилі APA, Harvard, Vancouver, ISO та ін.

Bodoki, Andreea E., Bogdan-C. Iacob, Elena Dinte, Oliviu Vostinaru, Ovidiu Samoila, and Ede Bodoki. "Perspectives of Molecularly Imprinted Polymer-Based Drug Delivery Systems in Ocular Therapy." Polymers 13, no. 21 (October 23, 2021): 3649. http://dx.doi.org/10.3390/polym13213649.

Повний текст джерела

Анотація:

Although the human eye is an easily accessible sensory organ, it remains a challenge for drug administration due to the presence of several anatomical and physiological barriers which limit the access of drugs to its internal structures. Molecular imprinting technology may be considered the avant-garde approach in advanced drug delivery applications and, in particular, in ocular therapy. In fact, molecularly imprinted polymers hold the promise to compensate for the current shortcomings of the available arsenal of drug delivery systems intended for ocular therapy. The present manuscript aims to review the recent advances, the current challenges and most importantly to raise awareness on the underexplored potential and future perspectives of molecularly imprinted polymer-based drug delivery systems intended for the treatment of eye diseases.

Стилі APA, Harvard, Vancouver, ISO та ін.

Більше джерел

Дисертації з теми "Ocular plastics"

Ricci, Marcos Desiderio. "Impacto da mamoplastia redutora contralateral, em pacientes com câncer de mama, na detecção de carcinoma oculto sincrônico e diminuição no risco de carcinoma metacrônico." Universidade de São Paulo, 2005. http://www.teses.usp.br/teses/disponiveis/5/5139/tde-20092010-180741/.

Повний текст джерела

Анотація:

INTRODUÇÃO: O principal fator de risco para câncer de mama é o antecedente pessoal de câncer na mama contralateral. A mamoplastia redutora de finalidade estética, tem sido implicada com redução no risco para câncer de mama. A mamoplastia redutora contralateral de simetrização, em pacientes operadas por câncer, contribui no diagnóstico de lesões precursoras e carcinoma oculto. OBJETIVOS: Determinar a ocorrência de lesões precursoras e carcinoma oculto de mama, em pacientes submetidas a mamoplastia redutora de simetrização. Comparar estas pacientes, com um grupo controle de pacientes não submetidas a tal cirurgia, analisando o tempo de início da terapia adjuvante quimioterapia ou radioterapia -, tempo livre de doença e sobrevida total, taxa de ocorrência e fatores relacionados com o câncer metacrônico. MÉTODOS: Estudaram-se 249 mulheres com diagnóstico de carcinoma invasivo de mama não metastático, divididas em dois grupos. O grupo estudo, constituído por 114 mulheres submetidas a mamoplastia redutora contralateral, e o grupo controle, constituído por 135 pacientes não submetidas a esta cirurgia. Foram excluídas do estudo todas as pacientes que apresentaram lesões suspeitas na mama oposta, bem como aquelas com antecedente de mamoplastia redutora. RESULTADOS: As pacientes submetidas a mamoplastia redutora de simetrização tiveram diagnóstico de carcinoma invasivo oculto sincrônico em 1,8% dos casos, carcinoma ductal in situ em 2,6%, e lesões proliferativas atípicas em 14,9%. O tempo de início da terapia adjuvante não foi influenciado pela mamoplastia de simetrização (p=0,826). Nas pacientes submetidas a mamoplastia, o câncer contralateral metacrônico ocorreu em 1,8% dos casos, enquanto que no grupo controle em 6,7%, demonstrando indícios de associação entre mamoplastia redutora contralateral e redução na ocorrência de câncer metacrônico (p=0,094). O tempo livre de doença e sobrevida total não foi influenciado pela mamoplastia. Os fatores relacionados com maior ocorrência foram os antecedentes familiares e o diagnóstico do tumor contralateral em estádio inicial. A quimioterapia adjuvante esteve relacionada com diminuição da ocorrência. CONCLUSÕES: A mamoplastia redutora contralateral de simetrização oferece uma oportunidade de diagnóstico de lesões de risco, tumores in situ e invasivos, além de demonstrar indícios de redução da ocorrência de câncer metacrônico durante seguimento oncológico.
INTRODUCTION: The principal risk factor for breast cancer is a personal antecedent of contralateral breast cancer. A reduction mammoplasty has an esthetical purpose and implies in the reduction of the risk of breast cancer. The contralateral and reduction mammoplasty with simetrization in patients with cancer and submitted to surgeries, contributes for the diagnosis of precursor lesions and occult carcinoma. OBJECTIVES: Determine the occurrence of precursor lesions and breast occult carcinoma in patients submitted to reduction mammoplasty with simetrization. Compare these patients with a control group of patients that were not submitted to that type of surgery, analyzing the time of initiating of the adjuvant therapy (chemotherapy and radiotherapy), disease-free time and total survival, occurrence tax and factors related with metachronic cancer. METHODS: 249 women with diagnosis of non-metastatic invasive breast carcinoma were studied and divided in two groups. The studied group was constituted of 114 women, who were submitted to reduction and contralateral mammoplasty, and the control group constituted of 135 patients, who were not submitted to this type of surgery. All the patients suspected to have lesions on the contralateral breast were excluded from this study, as well as, those with antecedents of reduction mammoplasty. RESULTS: The patients submitted to reduction mammoplasty with simetrization had a diagnosis of an occult, synchronic and invasive carcinoma in 1.8% of the cases, ductal carcinoma in situ in 2.6%, and proliferative and atypical lesions were found in 14.9%. The time of initiating the adjuvant therapy had no influence with the mammoplasty of simetrization (p=0.826). Patients submitted to mammoplasty, metachronic contralateral cancer occurred in 1.8% of the cases, whereas the control group demonstrated in 6.7% evidencing association between contralateral and reduction mammoplasty of occurrence of metachronic cancer (p=0.094). The disease-free time of the disease and total survival was not influenced by the mammoplasty. The factors related with a greater occurrence were the familiar antecedents and the diagnosis of the contralateral tumor in initial stage. The adjuvant chemotherapy adjuvant was related with the reduction of the occurrence. CONCLUSIONS: The contralateral and reduction mammoplasty with simetrization gives an opportunity for diagnosis of risk lesions, in situ and invasive tumors, besides demonstrating evidences of reduction of metachronic cancer during the oncological follow-up.

Стилі APA, Harvard, Vancouver, ISO та ін.

Knowles, Peter Timothy. "The outcome of ocular prosthetic (artificial eye) reconstruction." Thesis, 2018. http://hdl.handle.net/2440/118126.

Повний текст джерела

Анотація:

Eye loss has been a feature of mankind’s existence down through the ages, and whilst significant amounts of research have been undertaken to discuss monocular vision at an ophthalmic and optometric level, little or no research has been undertaken to discuss the benefits or otherwise of prosthetic reconstruction of the empty palprebal fissure. Most of this has been left at an artistic or anecdotal level. To the author’s knowledge, no research of this kind has been undertaken within Australia, and little or no research has been undertaken, to this extent, around the world. The overall aim of this research is to define the optimum benefit with the minimum risk for the different types of eye loss and ocular replacement. This thesis attempts to research and document the reasons for eye loss and some of the more prevalent issues that arise as a result of wearing an artificial eye, whether they be negative or positive. A questionnaire was developed, to research and quantify various experiences of individual artificial eye wearers; their reasons for eye loss, the role the prosthetic eye played in their life, both prosthetically, socially and psychologically. Every attempt has been made to accurately represent the responses based upon feelings of a number of patients over a number of years. The point of commonality in this study is that all patients have had their artificial eyes made by a single ocular prosthetist. It was found that eye loss was indiscriminate as to gender, age or ethnicity. The results showed that more people lost their right eye than those who lost their left, and over 50 age bracket lost their eye through disease more commonly. It was also hypothesized and confirmed that smokers lost their eye due to disease related issues more often than non-smokers. Prosthetic rehabilitation dramatically increased patients’ sense of wellbeing, emotionally, psychologically and socially. It is concluded that more than just being a cosmetic solution to what is otherwise a medical problem that an ocular prosthesis plays a more important, and vital, psychological role to those suffering eye loss.
Thesis (MClinSc) -- University of Adelaide, Adelaide Dental School, 2018

Стилі APA, Harvard, Vancouver, ISO та ін.

Книги з теми "Ocular plastics"

Ophthalmic plastic and reconstructive surgery. Stuttgart: Thieme, 1986.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

E, Wesley Ralph, ed. Techniques in ophthalmic plastic surgery. New York: Wiley, 1986.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

C, Naugle Thomas, Hesse Richard J, and Fry Constance L, eds. Diagnosis and management of oculoplastic and orbital disorders: Proceedings of the 43rd Annual Symposium, New Orleans, LA, USA, February 18-20, 1994, organized by the New Orleans Academy of Ophthalmology. Amsterdam: Kluger Publications, 1995.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Guthoff, Rudolf. Oculoplastics and orbit: Aesthetic and functional oculotfacialo plastic problem-solving in the 21st century. Berlin: Springer, 2010.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Color Atlas and Text of Ocular Plastic Surgery. C.V. Mosby, 1996.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Jordan, David, Louise Mawn, and Richard L. Anderson. Surgical Anatomy of the Ocular Adnexa. Oxford University Press, 2012. http://dx.doi.org/10.1093/oso/9780199744268.001.0001.

Повний текст джерела

Анотація:

Surgical Anatomy of the Ocular Adnexa is a beautifully and thoughtfully illustrated anatomical text that provides the ophthalmic surgeon or any surgeon working in the eyelid/orbital region with detailed yet concise, easy to read and understand descriptions of the anatomy in any particular region of the eyelid, orbit or nasolacrimal system. Throughout the text are clinical pearls and vignettes to help the reader appreciate why certain anatomical features are important to understand. Key anatomical concepts are highlighted and easy to visualize with real cadaver photos as well as the artists rendition of the same region. This book: - Develops a thorough understanding of the anatomy in the eyelid, orbit, nasolacriaml and periocular regions. - Fosters an appreciation of how knowledge of the anatomy leads to a better understanding of the pathophysiology of various disease processes involving the eyelid, orbit, nasolacrimal and periocular region. - Conveys the importance of anatomy in the surgical approach to various disease processes in the eyelid, orbit, nasolacrimal and periocular regions. This second edition will be an invaluable guidel to all those working in the eyelid, orbital, and nasolacrimal areas including residents, fellows and staff in ophthalmology, otolaryngology/head and neck surgery, plastic surgery and neurosurgeons working in and around the orbit.

Стилі APA, Harvard, Vancouver, ISO та ін.

R, Levine Mark, ed. Manual of oculoplastic surgery. 2nd ed. Boston: Butterworth-Heinemann, 1996.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

C, Allen Richard, and Mark R. Levine. Manual of Oculoplastic Surgery. Springer International Publishing AG, 2018.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Bosniak, Stephen. Oculo-Facial Surgery, An Issue of Otolaryngologic Clinics. Saunders, 2005.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

1908-, Smith Byron C., ed. Ophthalmic plastic and reconstructive surgery. St. Louis: Mosby, 1987.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Більше джерел

Частини книг з теми "Ocular plastics"

Levine, Mark R. "Ocular Cicatricial Pemphigoid." In Smith and Nesi’s Ophthalmic Plastic and Reconstructive Surgery, 355–57. New York, NY: Springer New York, 2011. http://dx.doi.org/10.1007/978-1-4614-0971-7_22.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Vegunta, Sravanthi, and Alison V. Crum. "Ocular Cicatricial Pemphigoid." In Smith and Nesi’s Ophthalmic Plastic and Reconstructive Surgery, 231–39. Cham: Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-41720-8_12.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Murchison, Ann P., and Jurij R. Bilyk. "Ocular Adnexal Lymphoproliferative Disease." In Smith and Nesi’s Ophthalmic Plastic and Reconstructive Surgery, 959–92. New York, NY: Springer New York, 2011. http://dx.doi.org/10.1007/978-1-4614-0971-7_60.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Bilyk, Jurij R., and Ann P. Murchison. "Ocular Adnexal Lymphoproliferative Disease." In Smith and Nesi’s Ophthalmic Plastic and Reconstructive Surgery, 769–816. Cham: Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-41720-8_50.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Shinder, Roman, and Bita Esmaeli. "Eyelid and Ocular Adnexal Reconstruction." In Smith and Nesi’s Ophthalmic Plastic and Reconstructive Surgery, 551–69. New York, NY: Springer New York, 2011. http://dx.doi.org/10.1007/978-1-4614-0971-7_36.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Rattan, Ginger Henson, Dwight R. Kulwin, Mark R. Levine, Adham Al-Hariri, Jaime S. Schwartz, and Kara Couch. "Management of Ocular Adnexal Trauma." In Smith and Nesi’s Ophthalmic Plastic and Reconstructive Surgery, 207–27. New York, NY: Springer New York, 2011. http://dx.doi.org/10.1007/978-1-4614-0971-7_9.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Shinder, Roman, and Bita Esmaeli. "Eyelid and Ocular Adnexal Reconstruction." In Smith and Nesi’s Ophthalmic Plastic and Reconstructive Surgery, 439–58. Cham: Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-41720-8_26.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Lever, Jackson F., Anne Barmettler, and Mark R. Levine. "Management of Ocular Adnexal Trauma." In Smith and Nesi’s Ophthalmic Plastic and Reconstructive Surgery, 1201–22. Cham: Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-41720-8_67.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Chen, Jiaqi, Jianjun Gu, and Jiajie Zhai. "Boston Type I Keratoprosthesis in Ocular Chemical Burns." In Plastic and Thoracic Surgery, Orthopedics and Ophthalmology, 111–22. Cham: Springer International Publishing, 2018. http://dx.doi.org/10.1007/15695_2017_67.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Lemke, Bradley N., and Mark J. Lucarelli. "Anatomy of the Ocular Adnexa, Orbit, and Related Facial Structures." In Smith and Nesi’s Ophthalmic Plastic and Reconstructive Surgery, 3–58. New York, NY: Springer New York, 2011. http://dx.doi.org/10.1007/978-1-4614-0971-7_1.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Тези доповідей конференцій з теми "Ocular plastics"

Jillela, Raghavender, and Arun Ross. "Mitigating effects of plastic surgery: Fusing face and ocular biometrics." In 2012 IEEE Fifth International Conference On Biometrics: Theory, Applications And Systems (BTAS). IEEE, 2012. http://dx.doi.org/10.1109/btas.2012.6374607.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Ми пропонуємо знижки на всі преміум-плани для авторів, чиї праці увійшли до тематичних добірок літератури. Зв'яжіться з нами, щоб отримати унікальний промокод!